Removing genetic effects on plasma proteins enhances their utility as disease biomarkers
Preprint
Abstract
Plasma protein levels are influenced by both genetic and non-genetic factors and can serve as early disease biomarkers. When a protein is correlated with, but not causally linked to, disease, its genetic determinants can add unwanted variability to protein–disease associations. In such cases, removing the genetic component may improve their predictive performances. Here, we tested this hypothesis by genetically adjusting 94 highly heritable proteins spanning diverse biological pathways and evaluating their associations with the onset of 37 diseases in 39,871 UK Biobank participants. Genetically adjusted proteins showed stronger associations in 88% of 1,312 significant protein–disease pairs, equivalent to a 30% median reduction in required sample size for comparable power. Of 96 protein–disease pairs with significant differences, all but one showed larger effects for adjusted proteins. Most proteins also showed consistently stronger associations with environmental and lifestyle factors once genetic effects were removed. Finally, we constructed multi-protein scores from genetically adjusted proteins and demonstrated that they significantly improve prediction for 7 diseases compared to unadjusted proteins. These findings demonstrate that removing genetic effects from plasma proteins is an effective strategy to increase power for biomarker discovery and clinical trial design, consistent with the largely non-causal role of most plasma proteins in disease risk.Keywords
This publication has 35 references indexed in Scilit:
- Atlas of the plasma proteome in health and disease in 53,026 adultsCell, 2024
- A unified framework for estimating country-specific cumulative incidence for 18 diseases stratified by polygenic riskNature Communications, 2024
- Inferring disease architecture and predictive ability with LDpred2-autoThe American Journal of Human Genetics, 2023
- An agonistic anti-signal regulatory protein α antibody for chronic inflammatory diseasesCell Reports Medicine, 2023
- An atlas of genetic scores to predict multi-omic traitsNature, 2023
- Proximity Extension Assay in Combination with Next-Generation Sequencing for High-throughput Proteome-wide AnalysisMolecular & Cellular Proteomics, 2021
- The CD47-SIRPα Immune CheckpointImmunity, 2020
- Genomic atlas of the human plasma proteomeNature, 2018
- Common SNPs explain a large proportion of the heritability for human heightNature Genetics, 2010
- Increase of expression and activation of chemokine CCL15 in chronic renal failureBiochemical and Biophysical Research Communications, 2006